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The default response of the intestinal immune system to most antigens is the induction of
immunological tolerance, which is difficult to reconcile with the constant exposure to
ligands for TLR and other pattern recognition receptors. We showed previously that
dendritic cells (DC) from the lamina propria of normal mouse intestine may be inherently
tolerogenic and herewe haveexplored how this might relate to the expression and function
of Toll-like receptors (TLR). Lamina propria (LP) DC showed higher levels of TLR 2, 3, 4 and 9
proteinexpression than spleen and MLN DC, with most TLR-expressing DC in the gut being
CD11c
lo, class II MHC
lo, CD103
–, CD11b
– and F4/80
–. TLR expression by lamina propria DC
was low in the upper small intestine and higher in distal small intestine and colon. Freshly
isolated lamina propria DC expressed some CD40, CD80, CD86 and functional CCR7. These
were up-regulated on CD11c
lo, but not on CD11c
hi LP DC by stimulation via TLR. However,
there was little induction of IL-12 by either subset in response to TLR ligation. This was
associated with constitutive IL-10 production and was reversed by blocking IL-10 function.
Thus, IL-10 may maintain LP DC in a partially unresponsive state to TLR ligation, allowing
them to have a critical role in immune homeostasis in the gut.
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Introduction
The intestine has a vast surface area, which is exposed
continuouslytodietaryantigensandcommensalmicro-organisms,
as well as an array of different pathogens. Although the intestinal
immune system generates strong protective immunity against
invading organisms, responses to harmless antigens are tightly
regulated, so that unnecessary inflammation is prevented and
tolerance is induced [1]. In most compartments of the immune
system, this decision is determined by the way in which dendritic
cells (DC) present antigen to T lymphocytes. After infection by
pathogenic organisms or during inflammation, DC are activated to
express a full range of costimulatory molecules and pro-
inflammatory cytokines, ensuring the efficient activation of
effector T cells. However, DC also play a critical role in the
induction of tolerance to both self and foreign antigens, often
because they are in a “quiescent” state which allows them to
present peptide-MHC to specific T cells in the absence of full
costimulation [2].
Recent evidence has shown that there are many DC with this
“quiescent” phenotype in the intestine and its lymphoid organs.
Subsets of DC from Peyer's patches (PP), mesenteric lymph nodes
(MLN) and mucosal lamina propria (LP) have also been found to
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capable of polarising T cells towards a regulatory or anti-
inflammatory phenotype [1, 3]. Although the exact role of each
of these populations in tolerance to individual forms of intestinal
antigenremainstobeclarified,ourownandother previousstudies
indicated that DC inthe LPareparticularlyimportant after feeding
soluble proteins [3, 4]. A substantial proportion of such antigens is
taken up by these DC in situ and can then be presented to naive
T cells, probably after CCR7-dependent migration to the draining
MLN and transfer of in vivo loaded LP DC induces specific
tolerance in naive recipients [3, 5, 6]. Together, these findings
highlight the possibility that under physiological conditions,
immunomodulatory DC predominate in the LP and are important
for maintainingintestinalhomeostasis bypreventingtheinduction
of inflammatory T cells.
However, these results are somewhat paradoxical in view of
the fact that mucosal DC are in an environment rich in bacterial
products and especially with the recent evidence that LP DC can
contact and engulf luminal bacterial directly by extending
processes across the epithelial layer [7–9]. Commensal bacteria
can also be found in DC in gut-associated lymphoid organs [10]
and it is not at all clear why this constant interplay between the
residentfloraandlocalDCdoesnotprovokeinflammation.DCuse
a variety of molecules to sense microbial agents, of which the best
understood are the family of Toll-like receptors (TLR) [11].
Recognition of conserved pathogen-associated molecular patterns
(PAMP) by TLR normally induces activation of DC, and in our
previous work, we showed that the TLR 4 ligand bacterial
lipopolysaccharide (LPS) induced up-regulation of CD40, CD80
and CD86 by LP DC. However, DC isolated from LP or intestinal
lymph fail to produce nitric oxide or mRNA for IL-12p40 in
response to LPS, suggesting that mucosal DC may be partially
refractory to activation via TLR [3, 12, 13]. Indeed, recent studies
suggest that TLR signalling actively down-regulates inflammation
in the intestine and are crucial to maintain intestinal immune
homeostasis [14–19].
Here, we haveexamined if aberrantresponsiveness of LPDC to
TLR ligands could account for their ability to recognise local
microbes without inducing inflammation by investigating the
expression and functions of a variety of TLR on DC isolated from
the intestine of normal mice. Our results show that although these
DC express high levels of several TLR and can up-regulate
costimulatory molecules and CCR7 in responsetoappropriate TLR
ligands, their secretion of pro-inflammatory cytokines is inhibited
by constitutive production of IL-10. Selective regulation of TLR
responsiveness may play a critical role in allowing local
microorganisms to be screened by mucosal DC without the risk
of unnecessary inflammation.
Results
Expression of TLR by DC in lamina propria, spleen
and MLN
In the first experiments, we analysed the expression of the various
TLR by DC from different tissues. Non-quantitative PCR analysis
showed expression of mRNA for TLR 2, 3, 4, 5 and 9 in MACS-
purified CD11c
+ cells from LP (Fig. 1A). A similar pattern was
found in spleen DC, indicating that both peripheral and mucosal
DC are capable of synthesising all TLR.
WenextdeterminedtheexpressionofTLRproteinsbyDCfrom
the different sites. While some TLR (TLR 1, 2, 4, 5 and 6) are
expressed on the cell surface, others (TLR 3, 7, 8, and 9) are found
almost exclusively in intracellular compartments such as endo-
somes, where they interact with internalised ligands such as
nucleic acids [11]. Therefore, we analysed the expression of TLR 3
and 9 in DC by intracellular staining and used surface staining to
assess TLR 2and 4expression (Fig.1B and C). Significantnumbers
of both spleen and LP DC expressed TLR 2, 3, 4 and 9 proteins, as
assessed by flow cytometry (Fig. 1B). Overall, significantly more
LP DC expressed TLR than in spleen, with the highest expression
being found for TLR 4, which was present on more than 40% of LP
DC (Fig. 1C). TLR expression by MLN DC was generally more
similar to spleen than LP (Fig. 1C). No antibodies are currently
availableto assess TLR 7 or 8 expression by flowcytometry and we
were unable to detect expression of TLR 5 using a selection of
different commercial antibodies (data not shown).
TLR expression by phenotypic and anatomical subsets
of mucosal DC
As we have shown previously [3], LP DC are a heterogeneous
population and therefore we examined TLR expression by
individual phenotypic subsets within these cells. First, we
comparedthe expression of TLRonputativemature and immature
LP DC. As described previously [3], a significant number of LP DC
have the CD11c
lo class II MHC
lo phenotype typical of immature DC
and many more of these cells expressed TLR 2 and 9 than the DC
withthe CD11c
hiclassIIMHC
hiphenotype of matureDC (75%and
55% for TLR 2 and 9 vs. 22.5% and 17.5%, respectively; Fig. 2).
Recently, it has been suggested that some of the CD11c
+ cells
foundinthesmallintestinalmucosamaybemacrophage-likecells,
as defined byexpression of high levelsof F4/80 [20].In ourhands,
around 30% of total CD11c
+ cells in LP expressed F4/80, but in
contrast to the earlier study, most of these cells were also CD11c
hi,
suggesting these were mainly of the DC lineage (data not shown).
Consistent with this, very few of the F4/80
+ CD11c
+ cells
expressed TLR 2 and 4 compared with the CD11c
+F4/80
– cells
(18% and 17% vs. 49% and 60% for TLR 2 and 4, respectively;
Fig. 3A). Interestingly, TLR expression was also lower on the
CD11b
+ subset of LP DC which contains most of the F4/80
+ cells,
than on the CD11c
+CD11b
– subset (16% and 20% vs. 57% and
62% for TLR 2 and 4, respectively; Fig. 3A).
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lo class II MHC
lo and CD11c
hi class II MHC
hi DC were identified among freshly isolated, enzymatically
digested small intestinal LP cells (left panel). The proportions of live gated CD11c
lo class II MHC
lo (black) and CD11c
hi class II MHC
hi (grey)
DC expressing surface TLR2 or intracellular TLR 9 are shown (right panel). The data shown are the percentages of TLR
+ cells out of live-gated (PI
–)
CD11c
+ cells in each tissue and are the mean   1 SD of three separate experiments.
Figure 1. TLR expression by DC in LP, spleen and MLN. (A) mRNA for TLR2, 3, 4, 5, 9 and GAPDH was identified by RT-PCR using MACS-purified CD11c
+
cells isolated by enzymatic digestion from the small intestinal LP and spleen. The results are representative of two repeat experiments.
(B) Representative flow cytometric analysis showing the surface expression of TLR2 and 4 and the intracellular expression of TLR3 and 9 by small
intestinalLPandspleenDC.Cellswereisolatedbyenzymaticdigestion,stainedwithFITCorPEantibodiesanti-CD11candFITCorPEantibodiesanti-
TLR, with dead cells gated out by staining with PI. The data shown are the proportion of live gated, CD11c
+ cells positive for each marker.
(C) Proportions of DC expressing surface TLR2 or 4, and intracellular TLR3 or 9 in LP (black), spleen (grey) and MLN (white) as assessed by flow
cytometric analysis as described in (B). The data shown are the percentages of TLR
+ cells out of live-gated (PI
–) CD11c
+ cells in each tissue and arethe
mean + 1 SD of three separate experiments.
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+CD11b
–F4/80
–). CD11c
+TLR2
– and
CD11c
+TLR2
+ subsets of freshly-isolated LP cells were shown in the top left panel. The proportions of live-gated CD11c
+TLR2
– (black) and
CD11c
+TLR2
+ (grey) DC expressing surface F4/80 or CD11b are shown in the top right panel. CD11c
+TLR4
– and CD11c
+TLR4
+ subsets of freshly-
isolated LP cells were shown in the bottom left panel. The proportions of live-gated CD11c
+TLR4
– (black) and CD11c
+TLR4
+ (grey) DC expressing
surface F4/80 or CD11b are shown in the bottom right panel. (B) Expression of TLR by the CD11c
+B220
– and CD11c
+B220
+ DC subsets within the small
intestinal LP cells (left panel). Theproportions of live-gated CD11c
+B220
+(black)and CD11c
+B220
– (grey) DC expressing intracellular TLR3 or TLR9 are
shown (right panel). (C) Two subpopulation of DC CD11c
+CD103
+ (grey) and CD11c
+ CD103
– (black) were found in freshly isolated small intestinal LP
cells (left panel). The percentages of gated CD11c
+CD103
+ (grey) and CD11c
+CD103
– (black) DC expressing intracellular TLR9 or surface TLR3 are
shown (right panel). The data shown are the percentages of F4/80
+, CD11b
+ or TLR
+ cells out of live-gated (PI
–) CD11c
+ cells in each tissue and are the
mean + 1 SD of three separate experiments.
Ivan Monteleone et al. Eur. J. Immunol. 2008. 38: 1533–1547 1536
f 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.euTLR 9 is characteristically expressed by plasmacytoid DC
(pDC) [11] and we found previously that a substantial minority of
DC in LP expressed B220, which is also present on pDC [3].
Consistent with these being pDC, 95% of CD11c
+B220
+ DC from
LP expressed the PDCA-1 marker (data not shown) and a
significantly larger proportion of B220
+ LP DC expressed TLR 9
than B220
– DC (55% vs. 25%; Fig. 3B). A further subpopulation of
LP DC which has received recent attention is that expressing the
epithelial associated integrin CD103 and which is responsible for
converting naive T cells into gut homing Foxp3
+ Treg cells
[21–23]. In our hands, the majority of CD11c
hi cells in LP were
also CD103
+, while CD11c
lo LP DC were CD103
– or CD103
lo.
Consistent with this, more of the CD103
– DC expressed TLR 2 than
the CD103
+ subset (64% vs. 34%; Fig. 3C) and very few CD103
+
DC expressed TLR 9 (7% vs. 39%; Fig. 3C).
The fact that more mucosal DC expressed TLR than those in
organised lymphoid tissues suggested that LP DC might be
involved in interacting with local microorganisms. To examinethis
idea, we compared the expression of TLR on CD11c
+ cells isolated
from the LP of the upper jejunum, ileum and colon. As shown in
Fig. 4, the expression of TLR 2, 3, 4 and 9 increased dramatically
going down the intestine, with very low numbers found in the
relativelysterileuppersmallbowel,comparedwiththedistalsmall
intestine and colon.
TLR ligands induce phenotypic maturation of LP DC
In previous studies, we found that purified LP DC could up-
regulateexpressionofclassIIMHCandcostimulatorymoleculesin
response tothe TLR 4 ligand LPS, but failed to synthesise IL-12p40
mRNA after this stimulation [3]. However, more recent work has
suggested that LP DC from mouse small intestine may produce
proinflammatorycytokineswhenstimulated withtheTLR5ligand
flagellin[24].Toexplorethesediscrepancies,wecarriedoutamore
detailedstudyof theresponsesofLPDCtoavarietyofTLRligands.
Freshly isolated LP DC expressed variable but generally low
levels of the maturation markers CD40, CD80 and CD86. Both the
number of cells expressing these markers (Table 1) and the levels
of their expression (Fig. 5A) increased somewhat after overnight
culture in medium alone and even more markedly after addition
of bacterial lipoprotein (BLP), poly I:poly C (poly (I:C)), LPS,
flagellin or CpG, ligands for TLR 2, 3, 4, 5 and 9, respectively
(Table 1 and Fig. 5A). Consistent with their intracellular
localisation in acidic endosomes and as reported previously
[25], the effects of ligating TLR 3 or TLR 9 on CD40 up-regulation
were abolished by chloroquine (Fig. 5B). In contrast, the effects of
ligating the surface expressed TLR 2 or 4 were not affected by
chloroquine. The response to flagellin was partially inhibited,
consistent with recent reports that flagellin may be recognised by
both intracellular and extracellular receptors [26, 27]. As TLR
expression was markedly different on the CD11c
lo and CD11c
hi
subsets of LP DC, we sorted these populations by FACS and
compared their responses to TLR ligands. Around 30% of freshly
isolated CD11c
hi DC expressed CD40 and this did not change after
overnight culture in medium, LPS or CpG (Fig. 5C). In contrast,
10% or less of the CD11c
lo DC expressed CD40 when analysed
immediatelyafter isolationandthesenumbersincreasedmarkedly
afterovernightcultureinmedium,LPSorCpG,tolevelsequivalent
to those found among CD11c
hi cells (Fig. 5C). Thus, the
responsiveness of LP DC subsets to TLR stimulation correlates
with their expression of the relevant receptors.
An important aspect of maturation of tissue DC is up-
regulation of CCR7 and for mucosal DC to function in vivo, they
Figure4.TLRexpressiononLPDCatdifferentanatomicallocationsintheintestine.Theproportionsoffreshlyisolated,enzymaticallydigestedsmall
intestinal CD11c
+ LP cells expressing surface TLR2 or 4, and intracellular TLR 3 or 9 in the proximal or distal small intestine or colon. All data are the
mean + 1 SD of three separate experiments.
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expression of activation markers by LP DC.
(A) MACS-purified CD11c
+ cells isolated by
enzymatic digestion from the small intestinal
LP were cultured with medium alone, or with
different TLR ligands. After 12 h, DC were
analysed for the expression of CD40, CD80,
CD86 and class II MHC by flow cytometry.
Freshly isolated DC were analysed in parallel
as controls. The graph shows the MFI for
each marker on live gated CD11c
+ cells
(***p 0.05 vs. medium-treated and p<0.01 vs.
all TLR ligands; **p 0.05 vs. all TLR ligands).
(B) Activation of DC by intracellular TLR
requires endosomal acidification. MACS-
purified CD11c
+ LP DC were pre-treated with
2.5lg/mLchloroquine(CQ,black) orPBS (grey)
for 15 min and then stimulated for 12 h with
different TLR ligands, prior to CD40 expres-
sion analysis by flow cytometry. The graph
shows the MFI of CD40 expression on live
gated CD11c
+ cells (*p<0.005 vs. CD11c
+ cells
pretreated with PBS and stimulated with
poly(I:C);
#p<0.01 vs. CD11c
+ cells pre-treated
with PBS and stimulated with CpG;
##p<0.05
vs. CD11c
+ cells pretreated with PBS and
stimulated with flagellin). The data are the
mean + 1 SD of three separate experiments.
(C) CD11c
lo and CD11c
hi LP DC differ in their
response to TLR ligands. LP cells were FACS-
sorted into CD11c
hi (grey line) and CD11c
lo
(black line) subsets and the histograms show
CD40 expression on freshly isolated cells, or
after incubation in medium alone, LPS or CpG
for 12 h.
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[5]. Around 40% of LP DC expressed CCR7 when cultured in
medium for 8 h and this was increased substantially by all the TLR
ligands examined, with70–80% becoming CCR7
+ (Fig. 6A and B).
This CCR7 was functional, as TLR-stimulated LP DC migrated
much more efficiently in a chemotaxis assay in vitro in the
presence of CCL19 (Fig. 6C). As with CD40, the expression of
CCR7anditsinductionbyTLRligationvariedbetweentheCD11c
hi
and CD11c
lo subsets of LP DC. Freshly isolated CD11c
hi DC had
higher levels of CCR7 than the equivalent CD11c
lo subset, but
stimulation of CD11c
lo cells with LPS or CpG increased the
expression of CCR7 to levels equivalent to those seen in the
CD11c
hi subset, which showed no response to any of the stimuli
(Fig. 6D). Thus, stimulation of LP DC with TLR ligands induces
phenotypic maturation and allows the cells to become responsive
to CCR7 ligands.
LP DC have an IL-10-dependent inability to produce
IL-12 in response to TLR ligands
In our previous work, we found that LP DC did not up-regulate
IL-12p40 mRNA in response to LPS, but expressed IL-10 mRNA
constitutively [3]. We extended these findings here by measuring
cytokine protein levels and by examining the responses to the
range of TLR ligands we had found to produce phenotypic
activation. Stimulation of purified LP DC with BLP, poly (I:C),
LPS, flagellin or CpG did not induce secretion of IL-12p70 protein
above the very low background levels found using unstimulated
cells (Fig. 7A). Unlike the expression of phenotypic markers of
activation, the CD11c
hi or CD11c
lo subsets of LP DC showed no
differences in IL-12 production. In both cases, 10% or less of the
cells stained positively for intracellular IL-12p40 under resting
conditions and neither purified population showed any change
after overnight culture in medium, LPS or CpG (Fig. 7B). In
contrast,splenicDCproduced highlevelsofIL-12inresponsetoall
the TLR ligands. Unlike resting spleen DC, resting LP DC produced
detectable amounts of IL-10 under resting conditions and these
were further increased by TLR stimulation. TLR stimulated spleen
DC also produced enhanced levels of IL-10 (Fig. 7A).
AsIL-10isawell-knowninhibitorofIL-12production [28,29],
we examined whether the inability of LP DC to secrete IL-12 was
due to their constitutive production of IL-10. LP or spleen DC were
therefore treated with anti-IL-10R before stimulation with either
LPS or CpG and the numbers of IL-12-expressing cells determined
by intracellular staining. As shown in Fig. 7C, spleen DC showed
significant increases in IL-12-expressing cells after stimulation
with LPS or CpG and these responses were increased further in the
presence of anti-IL-10R. In contrast, LP DC again showed no
significant responsetoLPS, CpGaloneor with therat IgGantibody
control (data not show), but these responses were dramatically
increased by treatment with anti-IL-10R (Fig. 7C).
Thus, constitutive production of IL-10 may be responsible for
maintainingLPDCinapartiallyunresponsivestatetoTLRligation.
Discussion
The results presented here show that DC from normal small
intestinal mucosa express a wide variety of intra-cellular and
surface TLR, whose pattern of expression is determined by
anatomical location and phenotypic subset. These TLR are
functional, but are partially refractory to ligation, up-regulating
costimulatory molecules and CCR7, but showing an IL-10-
dependent inability to induce proinflammatory IL-12.
Previous studies have suggested that intestinal DC may be
refractory to stimulation with LPS [3, 12, 13], but we show here
that DC from the LP of normal mice constitutively express mRNA
for TLR 2, 3, 4, 5 and 9. In addition, similar or greater numbers of
mucosal DC expressed surface TLR 2 and 4 and intracellular TLR 3
or 9 proteins compared with DC in spleen or MLN. The expression
and function of TLR in LP DC varied with the phenotypic subset,
withmore CD11c
lo classII MHC
lo DC expressing all TLR than those
with the CD11c
hi class II MHC
hi phenotype. In parallel, although
Table 1. Effects of TLR ligation on the expression of activation markers by LP DC
a)
Stimulus Class II MHC CD40 CD80 CD86
Freshly isolated 66   7% 25   6% 50   7% 42   6%
Medium 76   5% 50   5% 64   2% 70   2%
BLP 88   7% 71   4% 85   3% 85   3%
LPS 86   7% 67   4% 83   5% 80   4%
Poly (I:C) 88   3% 65   4% 79   3% 81   7%
Flagellin 89   3% 66   4% 83   6% 82   4%
CpG 86   8% 64   3% 80   5% 82   6%
a) MACS-purified CD11c
+ cells isolated by enzymatic digestion from the small intestinal LP were culturedwith medium alone, or with BLP, poly(I:C),
LPS,flagellin orCpG.After 12 h,the DC were analysedforthe expressionof CD40,CD80,CD86 and classII MHC by flowcytometry.Freshlyisolated
DC were analysed in parallel as controls. The data shown are the percentage of live-gated CD11c
+ cells expressing each marker and are the
means   1 SD of three separate experiments.
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hi class II MHC
hi DC expressed higher levels of
costimulatory molecules and CCR7 under resting conditions,
these molecules were only up-regulated by TLR ligation in the
CD11c
lo class II MHC
lo subset. The nature of this TLR expressing,
CD11c
lo class II MHC
lo subset remains to be determined, with one
possibility being that they represent recently recruited immature
DC,whereastheCD11c
hiclassIIMHC
hicellshavethephenotypeof
classical mature DC. It should be noted that TLR expression was
also dependent on whether LP DC expressed CD103, with much
higher numbers of CD103
– DC being positive for all TLR than their
CD103
+ counterparts. This was consistent with the fact that most
CD103
+ DC were also CD11c
hi class II MHC
hi and it also supports
other recent findings that CD103
– DC in MLN express higher levels
of mRNA for TLR 2 and 4 than the CD103
+ subset [22]. As recent
work suggests that CD103
+ and CD103
– DC in the gut may be
independent subsets with distinct functions ([22] and our
unpublished observations), it is also feasible that the CD11c
lo
and CD11c
hi subsets of LP DC may not simply represent different
stages of maturation of the same cell lineage. Notably, a very
recent report has proposed that a significant number of the
CD11c
lo cells found in mouse small intestinal mucosa, which fail to
produce pro-inflammatory mediators in response to TLR ligation
may be macrophage-like, based on the expression of F4/80 [20].
However, our CD11c
loTLR
+ LP cells appear to be different tothese
cells, as they are mostly CD11b
negF4/80
neg and class II MHC
lo,i n
contrast to the CD11b
+F4/80
+ and class II MHC
hi phenotype
reported by Denning et al. In contrast, the smaller population of
F4/80
+ cells in our preparations were mainly CD11c
hi and
expressed low levels of TLR. The reasons for these discrepancies
are unclear, but could reflect differences in isolationprocedures or
in the microbial flora present in the different animal facilities. We
are now exploring the lineage-function relationships of the
different phenotypic subsets of TLR expressing LP DC in more
detail.
The proportions of TLR expressing LP DC also varied
depending on the anatomical location, with the numbers
increasing markedly going down the intestine and being maximal
in the colon and distal small intestine. As these are the sites with
the highest bacterial load, these findings indicate that TLR
expression by intestinal DC may be regulated by the local flora. An
identical pattern of TLR 2, 4 and CD14 mRNA expression has been
reported at different sites of the mouse intestine, although this
study mainly analysed mucosal homogenates and could only
locate TLR 4 on epithelial cells and unidentified mucosal
mononuclear cells [30]. Our work suggests these latter cells
may have been DC. Ortega-Cava et al. [30] finding that MyD88
was expressed throughout the small and large intestine and our
evidence that individual TLR are present on DC from all parts of
the intestine contrast with a recent report that LP DC from mouse
small intestine do notexpress TLR 4 mRNA [24]. Human intestinal
DC also express TLR 4 [13] and as our purified CD11c
+ DC
responded to stimulation with the TLR 4 ligand LPS, these results
indicate that functional TLR 4 is indeed expressed by mucosal DC.
While we were able to confirm previous work that LP DC express
high levels of TLR 5 mRNA [24], we were unable to obtain a
suitable antibody to confirm expression of the TLR 5 protein and
this requires further investigation.
Our study is first to have identified intracellular TLR 3 and 9 in
mucosal DC, although TLR 9 has been found previously in
intestinal epithelial cells and in uncharacterised LP cells [31, 32].
In our hands, TLR 9 was expressed predominantly by the subset of
LP DC with the PDCA-1
+B220
+ phenotype of plasmacytoid DC, as
has been reported in other tissues [11], Others have recently
shown a small population of plasmacytoid DC in mouse LP [33]
and the potential importance of these cells is demonstrated by the
fact that TLR 9 is needed for protective immunity during small
intestinal toxoplasmosis in mice [32] and to protect mice from
DSS-induced colitis [34]. Unlike TLR 2- and TLR 4-mediated
responses, we found that TLR 9 (and TLR 3) functioned in an
acidic intracellular compartment, as has been described before
[11]. However, as with the other TLR, stimulation of TLR 9 on LP
DC with CpG motifs produced only partial activation, with in
particular, no production of the IL-12 which characterises TLR 9
responses by other DC [35]. It will be of interest to examine
whether the refractoriness to TLR 9 stimulation also affects other
characteristic downstream effects, such as type 1 IFN production.
In our previous work, we found that LP DC expressed mRNA for
type 1 IFN constitutively, but this was not increased further by
stimulation with LPS, perhaps consistent with TLR unresponsive-
ness [3]. However, in these experiments, we did not examine TLR
9 stimulation of LP DC and it will be important to explore the basis
of this phenomenon more precisely.
The global refractoriness in TLR responsiveness we have
identified is clearly distinct from the phenomenon of classical
endotoxin tolerance in which chronic exposure of macrophages to
BLP, LPS or CpG leads to selective down-regulation of the cognate
TLR [36–38]. However, cross tolerance has also been described, in
which exposure to one ligand inhibits downstream signalling from
·
Figure 6. TLR stimulation enhances functional CCR7 expression by LP DC. (A) Representative flow cytometric analysis of CCR7 expression on live
gated, MACS-purified CD11c
+ cells from small intestinal LP stained with PE anti-CCR7 after stimulation for 6 h with medium alone, or with different
TLR ligands. (B) Overall levels of expression of CCR7 on live gated, MACS-purified CD11c
+ cells from small intestinal LP after stimulation for 6 h
with medium alone or with different TLR ligands (**p<0.001 vs. BLP and LPS stimulation, p<0.005 vs. all other TLR stimulations). The data are the
means + 1 SD of three separate experiments. (C) Chemotaxis of LP DC to CCR7 ligand CCL19. MACS-purified CD11c
+ cells from small intestinal LP
were cultured in medium, or with different TLR ligands for 4 h before being placed on the top of a transwell membrane and allowed to migrate in
response to CCL19 (MIP-3b) in the bottom chamber. The number of CD11c
+ cells which had migrated into the bottom chamber was determined by
flow cytometry (***p 0.001 vs. all TLR ligands). (D) CD11c
lo and CD11c
hi LP DC differ in their response to TLR ligands. LP cells were FACS-sorted into
CD11c
hi(greyline)andCD11c
lo(blackline)subsetsandthe histogramsshowCCR7 expressiononfreshlyisolatedcells,orafterincubationin medium
alone, LPS or CpG for 12 h.
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production by LP DC in response to TLR stimulation. (A) Production of
IL-12p70 (top) and IL-10 (bottom) by purified MACS-purified CD11c
+ DC from
small intestinal LP (left) or spleen (right) after culture with medium alone or
with different TLR ligands for 24 h. Supernatantswere analysed by sandwich
ELISA and the results shown are pg/mL for duplicate cultures and are the
means + 1 SD of three separate experiments. (B) Both CD11c
lo and CD11c
hi LP
DC fail to produce IL-12 in response to TLR ligands. LP cells were FACS-sorted
into CD11c
hi (grey line) and CD11c
lo (black line) subsets and the histograms
show intracellular expression of IL-12p40 by freshly isolated cells, or after
overnight incubation with medium alone, LPS or CpG for 6 h. (C) MACS-
purified CD11c
+ DC from small intestinal LP or spleen were pre-treated with
medium alone or with 2 ng/mL of anti-IL10 receptor antibody for 60 min
before being stimulated with TLR ligands for 6 h. Intracellular IL-12p70 levels
were analysed by flow cytometry and the data shown are the percentage live
gatedCD11c
+cellspositiveforIL-12and arethemean+1SDofthreeseparate
experiments. **p 0.01 vs. LP DC preincubated with anti-IL10R and LPS;
***p<0.05 vs. LP DC preincubated with anti-IL10R and CpG.
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A generalised phenomenon of this kind might be expected in the
intestine, where LP DC are likely to be exposed continuously to
multiple TLR ligands. Cross tolerance has been associated with the
fact that many of the TLR link with MyD88, TRAF-6 and IRAK-1
adapter proteinsandtolerancetoLPScausesTLR4tofailtorecruit
MyD88 [41–43]. However, this mechanism appears to spare
responses to TLR 3 and in some cases to TLR 4, when TRIF and
TBK-1 are used as adapter proteins to induce downstream
signalling [11, 44, 45]. Our finding that LP DC were also
refractory to stimulation by the TLR 3 ligand poly (I:C) suggests a
different mechanism of hyporesponsiveness and we propose that
IL-10 may explain at least part of this phenomenon. As we showed
previously [3], we found here that LP DC produced significant
levels of IL-10 constitutively and now demonstrate that blocking
IL-10 signalling allowed these cells to produce IL-12 when
stimulated via TLR. Inhibition of pro-inflammatory cytokine
production by IL-10 is well known and IL-10 can replicate many of
the global effects of endotoxin tolerance in myeloid cells, a
phenomenon which can be partly prevented by neutralising IL-10
[46].IL-10mayactbyinterferingwiththeremodellingof theIL-12
p40 gene locus and/or by inactivating a subset of p40 transcrip-
tional activators [28]. Interestingly, IL-10-induced TLR hypor-
esponsiveness is associated with maintained receptor expression,
further supporting the idea that IL-10 may be responsible for the
functional defects we observed in LP DC.
Together, our results support the idea that autocrine produc-
tion of IL-10bymucosal DC mayunderlietheir inability torespond
fully toTLR and it is likely that this default IL-10 response reflects
conditioning effects of the local microenvironment [47]. This
could involve the large amounts of TGFb found in the gut and a
similar population of IL-10-producing DC has been described after
conditioning with TGFb-producing splenic stromal cells [48]. This
phenomenon is related to TGFb-mediated activation of ERK1/2
and failure to activate p38 in response to TLR. Alternative
conditioning factors could include TSLP released by intestinal
epithelial cells [49, 50], or PGE2 released by TLR-activated
mucosal stromal cells [51, 52]. Additionally, initial stimulation of
TLR on immature DC arriving in the mucosa could prime for
selective production of IL-10 and inhibition of IL-12 on subsequent
encounters with PAMP, as has been shown with TLR 2 or 4 in vitro
[53]. This process is also dependent on selective activation of
ERK1/2. That this mayoccur in the normal gut is supported by the
finding that individual commensal bacteria can also prime IL-10
production by immature DC in vitro [54, 55], thus setting up a
feedback loop with IL-10 at its core.
Insummary,our resultsareconsistent with the hypothesis that
LP DC areconditioned byintestinal bacteria and otherlocalfactors
to develop IL-10-dependent unresponsiveness to inflammatory
stimuli such as TLR ligands. We propose that this allows LP DC to
play a central role in maintaining homeostasis to dietary proteins
andcommensal bacteria.Severalpopulationsof intestinal DChave
been shown to produce IL-10 and in PP this is associated
particularly with the CD8a
– subset [56]. In the LP, it has been
suggested that IL-10 production is a selective property of the
CD11c
loF4/80
+ “macrophage-like” subset [20], but we found that
neither CD11c
lo nor CD11c
hi LP DC produced IL-12 in response to
TLR stimulation. Therefore, we are currently investigating the role
of the individual phenotypic subsets in the production of IL-10.
It will be of particular interest to explore the role of the CD103
+
subset in this phenomenon, as these cells in LP and MLN have
recently been shown to have a selective ability to induce the
generationofFoxP3
+Treginvitro[21,22].ThisrequiresTGFband
retinoic acid, but the role of IL-10 has not yet been explored.
Importantly, we found that despite their partial refractoriness to
activation, LP DC expressed significant levels of CCR7 and this was
enhanced by TLR stimulation. CCR7-expressing DC also migrated
in vitro in response to CCL19, indicating that they would have the
capacity to emigrate to the draining MLN in vivo even under non-
inflammatory conditions. This is consistent with the considerable
trafficking of mucosal DC into lymph, which occurs in resting
animals [50], and with the evidence that constitutive migration of
resting tissue DC to LN is a central component of self-tolerance
[57]. More specifically, recent studies show that the induction of
tolerance to orally or intranasally administered antigens requires
CCR7-dependent migration of antigen-loaded DC from the gut
mucosa or lung parenchyma to the draining LN [6, 58]. Our data
suggest that IL-10-dependent refractoriness of mucosal DC allows
this crucial homeostatic process to be maintained in the intestine,
allowing uptake and presentation of harmless antigens toTcells in
organised lymphoid tissues, but ensuring tolerance is the result.
Mice
Female BALB/c mice were obtained from Harlan Olac (Bicester,
UK). All mice were first used at 8 weeks of age and were
maintainedunderSPFconditionsattheCommonResearchFacility
of the University of Glasgow.
Treatment of mice with flt3 ligand
Mice were injected daily i.p. with 10 lg recombinant human flt3L
(kindly provided by Amgen, Seattle, WA) in saline for 7–10 days
before harvest of DC.
Isolation of cells from lymphoid tissues
Single-cell suspensions were prepared fromMLNand spleen either
by gently mashing through nylon mesh filters (Becton Dickinson,
BD; Cowley, UK), resuspended in RPMI 1640 (Life Technologies,
Paisley, UK) or by digestion for 20 min at 37
 C with 100 U/mL
collagenase (type VIII; Sigma, Poole, UK) and 30 lg/mL DNase I
(Roche Diagnostic, Lewes, UK) in calcium- and magnesium-free
HBSS (CMF; Life Technologies) containing 10% FBS (Life
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by phase contrast microscopy and kept in RPMI with 10% FBS.
Isolation of LP cells
Small intestines and colons were washed in HBSS and the PP
excised. To obtain LP cells, the guts were opened longitudinally,
cut into small pieces and washed thoroughly in HBSS before being
incubatedinHBSScontaining2 mMEDTA(Sigma)for15 minina
shaker at 37
 C. The epithelial layer was then removed by shaking
the pieces of intestine twice thoroughly in HBSS and the
incubation process repeated for four cycles. The remaining
fragments of intestinal tissue were then incubated with 100 U/
mL Collagenase and 30 lg/mL DNase I in RPMI/10% FBS at 37
 C
for 45 min. The fragments were then disrupted by shaking and the
supernatants collected. After repeating the process three times,
supernatants were passed through Nitex mesh, washed and stored
in RPMI/10% FBS.
Purification of DC
CD11c
+ DC were purified from the intestine and spleen by MACS
according to the manufacturer's instructions (Miltenyi Biotec).
Briefly, cells were incubated with MicroBeads conjugated anti-
CD11c (N418, Miltenyi Biotec) antibody and suspended in cold
MACS buffer (PBS + 0.5% BSA + 2 mM EDTA) for 15 min at 4
 C
and passed over MD MACS column (Miltenyi Biotec). Positively
selected cells were routinely found to contain 82–91% CD11c
+
cells by flow cytometry.
For sorting of DC into CD11c
hi and CD11c
lo subsets, LP cells
were first incubated with FITC-conjugated anti-CD11c mAb (HL3,
Hamster IgG; BD Biosciences) and then sorted on a FACSVantage
(Becton Dickinson) into CD11c
hi and CD11c
lo fractions. The purity
of the sorted DC subsets routinely exceeded 90% and 80%,
respectively.
Stimulation of DC with TLR ligands
To examine the response of DC to TLR stimuli, DC were
resuspended in RPMI/10% FBS and cultured at 1   10
6 cells/
mL in 24-well ultra-low attachment polystyrene plates (UltraLow
Cluster, Corning, Corning, USA) with 2 lg/mL BLP (Pam3CSK;
EMC Microcollection, Tubingen, Germany), 5 lg/mL poly (I:C)
(Invitrogen), 2 lg/mL Flagellin (Salmonella T.; Invitrogen), 5 lg/
mL LPS (E. coli, Sigma) or 5 lM CpG (ODN 1826, Invitrogen), for
4, 6, 8, 12 or 24 h at 37
 C. In some experiments, DC were
pretreated with chloroquine (2.5 lg/mL for 15 min, Sigma) or
withanti-IL-10R(2 ng/mLfor60 min,1B1.3a,BDPharMingen)or
the rat IgG control antibody before stimulation with TLR ligands.
Flow cytometry
Aliquots of spleen and intestinal DC were stained with PE, FITC or
biotinylated anti-CD11c (HL3, BD PharMingen) in combination
with FITC- or PE-antibodies against CD80 (16–10A1, BD
PharMingen), CD86 (GL1, BD PharMingen), MHC class II (I-A
b
25-9-17, BD PharMingen), B220 (RA3–6B2, BD PharMingen),
TLR-2 (6C2, E Bioscience), TLR-3 (T3.7C3, E Bioscience), TLR-4
(MTS510, E Bioscience), TLR-9 (M9.D6, E Bioscience), CCR7
(4B12, E Bioscience), IL-12(p40/p70) (C15.6, BD PharMingen),
F4/80 (BM8; Caltag Laboratories), CD11b (M1/70, BD
Bioscience). Appropriate isotype-matched controls from BD
PharMingen were included in all experiments. Biotinylated
antibodies were detected using streptavidin conjugated to
allophyocyanin (APC; BD PharMingen), and all staining proce-
dures were carried out using 1   10
5 to 5   10
5 cells in 200 lL
FACS buffer (PBS + 2% FBS and 0.05% sodium azide) for 30 min
at 4
 C in the dark. For intracellular staining cells were fixed with
1% formaldehyde for 10 min and subsequently permeabilized
with 0.5% saponin in 1% BSA FACS buffer, prior to staining with
anti-TLR 9, TLR 3 or IL-12 antibody. To exclude dead cells, 5 ng
propidium iodide (PI; Sigma) was added just before analysis and
cells were analyzed using a FACSCalibur cytometer and Cell-
QuestPro software.
Measurement of cytokine production in vitro
After 24 h of culture in medium or with TLR ligands, DC
supernatants were harvested, centrifuged and stored at –70
 C.
Cytokine production was quantified using sandwich ELlSA
techniques as previously described [59]. Cytokine concentrations
in test supernatants were determined with reference to a standard
curve constructed using serial dilutions of the standard cytokines
[59].
Assessment of chemotaxis in vitro
Total LP cells were resuspended at a final concentration of 2.5  
10
6/mL cells and cultured in 24-well tissue culture plates (Costar)
either in medium alone, or with the different TLR ligands for 6 h.
Of the cells suspension, 200 lL was then added to the upper
chambers of a Transwell chemotaxis plate (5-lm pores; Costar)
and400 lLofserum-freeRPMI1640containing 10 ng/mLCCL19/
MIP3b (PeproTeck) was placed in the lower chamber. The plate
was then incubated at 37
 C for 2 h and the cells that had migrated
intothe bottom chamber were stained with a FITC-anti-CD11c and
counted using a FACSCalibur cytometer and CellQuestPro soft-
ware.
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Total RNA was extracted from purified small intestinal LP DC and
spleen using the RNeasy Mini Kit extraction (Qiagen) according to
the manufacturer's instructions. The mRNA levels were quanti-
tated by absorbance at 260 nm and cDNA was synthesized from
5 lg of total RNA using 200 U of superscript II reverse
transcriptase, 2.5 lmol/L random hexamers, 1 lmol/L deoxy-
nucleoside and 40 U/mL of ribonuclease inhibitor (all from
Invitrogen)inatotalvolumeof25 lL.Thereactionwasperformed
at 42
 C for 50 min.
RT-PCR reactions were performed in a 1.1x Pre-aliquoted
ReddyMix PCR Master Mix 50 lL Reaction (ABgene) used as the
manufacturer's instructions with 25 pmol/L 50 and 30 primers and
2 lL cDNA. Reactions were incubated in FTGENE5D thermocycler
(Teche) for 35 cycles (denaturation 1 min at 94
 C, annealing for
1 min at 60
 C, and extension for 1 s at 72
 C) using the following
PCR primers: TLR 2 (50-CGTTGTTCCCTGTGTTGCT-30,5 0-
AAAGTGGTTGTCGCCTGCT-30); TLR 3 (50-TTGCGTTGCGAAGT-
GAAG-30,5 0-TAAAAAGAGCGAGGGGACAG-30); TLR 4 (50-
TTCACCTCTGCCTTCACTACA-30,5 0-GGGACTTCTCAACCTTCT-
CAA-30); TLR 5 (50-CAGGATGTTGGCTGGTTTCT-30,5 0-CGGA-
TAAAGCGTGGAGAGTT-30); TLR 9 (50-GAAAGCATCAACCACAC-
CAA-30,5 0-ACAAGTCCACAAAGCGAAGG-30); GAPDH (50-
AACTCCCACTCTTCCACCTT-30,5 0-GCCCCTCCTGTTATTATGG-
30). Of RT-PCR products, 10 lL was combined with 1 lLo f
loading buffer and electrophoresed on a 2% agarose gel (in 0.5x
TBEbuffer:0.275%Boricacid,2 mMEDTA,0.54%Trisbase).Gels
were analysed using the Gel Logic 200 imaging system.
Statistical analysis
Where appropriate, results were expressed as means   1 SD and
differences between groups were compared using Student's t-test.
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